NCT06622707

Brief Summary

Kinesio taping gently stretches the skin and creates a gap between the dermis and fascia, increasing lymphatic and vascular flow and reducing pain without restricting movement. It is used to provide rehabilitation after surgical operations. This study will be conducted to determine the effect of kinesio taping on the mother\'s pain and comfort after cesarean section. It is planned to include 60 women who gave birth by cesarean section in the obstetrics and gynecology department at Şırnak State Hospital. Research data will be collected with the visual analog scale and postpartum comfort scale. If the data shows normal distribution, Unrelated Samples t Test, Related Samples t Test and Repeated Measures ANOVA (Repeated Measures) tests will be used.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Nov 2024

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 29, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 2, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

November 5, 2024

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

March 2, 2025

Completed
Last Updated

October 2, 2024

Status Verified

September 1, 2024

Enrollment Period

3 months

First QC Date

September 29, 2024

Last Update Submit

September 29, 2024

Conditions

Keywords

Kinesio TapingPainPostpartum Comfort

Outcome Measures

Primary Outcomes (2)

  • vas

    It is used to measure subjectively perceived pain

    VAS will be applied at the 10th hour, 24th hour, 48th hour and 72nd hour after cesarean section.

  • Postpartum comfort questionnaire

    It is a scale that can be used appropriately and safely in measuring the postpartum comfort of mothers who have given birth normally or by cesarean section, in meeting the postpartum comfort needs, and in evaluating the outcome as a concrete indicator of the outcome.

    It will be filled in at the 10th and 72th hours after birth.

Study Arms (2)

kinesio taping group

EXPERIMENTAL

Kinesio taping will be applied to this group.

Other: kinesio tapingOther: Routine clinical care

control group

EXPERIMENTAL

Participants in this group will not receive any intervention other than routine clinical care.

Other: Routine clinical care

Interventions

Despite the increasing indications and new application techniques developed all over the world, it is believed that there is a need for evidence regarding the mechanisms of action and effectiveness of kinesio taping. As a result of the literature review, no study was found in which kinesio taping was applied for 72 hours as a non-pharmacological complementary method to reduce postoperative pain after cesarean section and increase postpartum comfort. In this study, it is planned to apply kinesiotaping for 72 hours after cesarean section.

kinesio taping group

As routine clinical care; Analgesic treatment protocol applied after cesarean section, postnatal care and discharge services are provided

control groupkinesio taping group

Eligibility Criteria

Age19 Years - 45 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsWomen who have had a cesarean section will be included in the study.
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • patients having C-section delivery in the 37th and 40th gestational weeks,
  • patients giving birth to just a baby,
  • patients with no chronic disease (such as allergy, diabetes, or hypertension),
  • patients having no problems with communication,
  • patients with no dermatological disease.

You may not qualify if:

  • patients whose babies are in the neonatal intensive care unit,
  • patients with deep vein thrombosis, open wounds, or skin irritation,
  • patients who did not want to participate in the study,

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Central Study Contacts

Kübra akcan lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

September 29, 2024

First Posted

October 2, 2024

Study Start

November 5, 2024

Primary Completion

January 20, 2025

Study Completion

March 2, 2025

Last Updated

October 2, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

I accept IPD sharing

Shared Documents
STUDY PROTOCOL